BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21870022)

  • 1. Second trimester prenatal screening for Down's syndrome in Mainland Chinese subjects using double-marker analysis of α-fetoprotein and β-human chorionic gonadotropin combined with measurement of nuchal fold thickness.
    Liu F; Liang H; Jiang X; Zhang Y; Xue L; Yang C; Cheng J; Liu P; Liu Y; Guo X
    Ann Acad Med Singap; 2011 Jul; 40(7):315-8. PubMed ID: 21870022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Second trimester maternal serum screening for Down's syndrome in mainland China: a multi-center prospective study].
    Bian XM; Liu JT; Qi QW; Jiang YL; Li Y; Liu SY; Hao N; Zhou J; Lü SM; Zhu BS; Wang H; Xu ZF; Pan XY; Liao C; Cai Y; Wang H; Wang Z; Zhu J; Hu YL
    Zhonghua Fu Chan Ke Za Zhi; 2008 Nov; 43(11):805-9. PubMed ID: 19087560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second trimester prenatal screening for Down's syndrome using alpha-fetoprotein and free beta hCG: a seven year review.
    Spencer K
    Br J Obstet Gynaecol; 1999 Dec; 106(12):1287-93. PubMed ID: 10609723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-trimester or second-trimester screening, or both, for Down's syndrome.
    Malone FD; Canick JA; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Dukes K; Bianchi DW; Rudnicka AR; Hackshaw AK; Lambert-Messerlian G; Wald NJ; D'Alton ME;
    N Engl J Med; 2005 Nov; 353(19):2001-11. PubMed ID: 16282175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.
    Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012599. PubMed ID: 28295159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Second trimester maternal serum screening for Down's syndrome in women of advanced maternal age: a multi-center prospective study].
    Qi QW; Jiang YL; Liu JT; Bian XM; Li Y; Lü SM; Zhu BS; Wang H; Xu ZF; Pan XY; Cai Y
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):737-41. PubMed ID: 19087538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
    Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK
    J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome.
    Spencer K; Crossley JA; Aitken DA; Nix AB; Dunstan FD; Williams K
    Ann Clin Biochem; 2003 May; 40(Pt 3):219-31. PubMed ID: 12803832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined ultrasound and biochemical screening for Down's syndrome in the first trimester: a Scottish multicentre study.
    Crossley JA; Aitken DA; Cameron AD; McBride E; Connor JM
    BJOG; 2002 Jun; 109(6):667-76. PubMed ID: 12118646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining fetal nuchal fold thickness with second-trimester biochemistry to screen for trisomy 21.
    Borrell A; Mercade I; Casals E; Borobio V; Seres A; Soler A; Fortuny A; Cuckle H
    Ultrasound Obstet Gynecol; 2007 Dec; 30(7):941-5. PubMed ID: 18000942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of maternal serum alpha-fetoprotein and free beta human chorionic gonadotrophin in the first trimester: implications for Down's syndrome screening.
    Berry E; Aitken DA; Crossley JA; Macri JN; Connor JM
    Prenat Diagn; 1995 Jun; 15(6):555-65. PubMed ID: 7544898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The best marker combination using the integrated screening test approach for detecting various chromosomal aneuploidies.
    Maymon R; Sharony R; Grinshpun-Cohen J; Itzhaky D; Herman A; Reish O
    J Perinat Med; 2005; 33(5):392-8. PubMed ID: 16238533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison and integration of first trimester fetal nuchal translucency and second trimester maternal serum screening for fetal Down syndrome.
    Lam YH; Lee CP; Sin SY; Tang R; Wong HS; Wong SF; Fong DY; Tang MH; Woo HH
    Prenat Diagn; 2002 Aug; 22(8):730-5. PubMed ID: 12210586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second trimester maternal serum screening using alpha fetoprotein, free beta human chorionic gonadotropin and maternal age specific risk: result of chromosomal abnormalities detected in screen positive for Down syndrome in an Asian population.
    Chao AS; Chung CL; Wu CD; Chang SD; Cheng PJ; Lin YT; Soong YK
    Acta Obstet Gynecol Scand; 1999 May; 78(5):393-7. PubMed ID: 10326883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    BJOG; 2004 Jun; 111(6):521-31. PubMed ID: 15198778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
    Hsu JJ; Hsieh TT; Soong YK; Spencer K
    Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations between maternal hepatitis B virus carrier status and Down's syndrome prenatal screening indicators and their effects on the screening results.
    Huang L; Chen Y; Ning W; Chen Y; Yu D
    J Obstet Gynaecol; 2022 Oct; 42(7):2793-2798. PubMed ID: 36036240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of maternal serum for fetal Down's syndrome in the first trimester.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Miller WA; Johnson A
    N Engl J Med; 1998 Apr; 338(14):955-61. PubMed ID: 9521983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.